A detailed history of Foster & Motley Inc transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Foster & Motley Inc holds 447 shares of VRTX stock, worth $224,595. This represents 0.01% of its overall portfolio holdings.

Number of Shares
447
Previous 460 2.83%
Holding current value
$224,595
Previous $216,000 3.7%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$460.0 - $505.78 $5,980 - $6,575
-13 Reduced 2.83%
447 $208,000
Q2 2024

Aug 02, 2024

BUY
$392.81 - $485.53 $180,692 - $223,343
460 New
460 $216,000
Q2 2023

Aug 08, 2023

BUY
$314.42 - $351.91 $179,848 - $201,292
572 New
572 $201,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Foster & Motley Inc Portfolio

Follow Foster & Motley Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foster & Motley Inc, based on Form 13F filings with the SEC.

News

Stay updated on Foster & Motley Inc with notifications on news.